Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- beauty
- cleaning
- industrial
- pharma
Magnesium oxide
EPA CPDat observed this chemical in 1856 composition records across product categories including Construction and building materials, Furniture and furnishings, Raw materials.
Concern score
Not assessed — no hazard data yet.
Where it appears
Prevalence of Magnesium oxide in our catalog (epa_cpdat).
Products
1,856
Brands
6
Construction and building materialsFurniture and furnishingsRaw materialsOther direct contact consumer goodsCleaning and safetyLaboratory supplies
Typical roles
AbsorbentAggregateBinderBreakerDegradant/impurityFlame retardantFlux agentMoulder
Found in these products
Dietfuel vegan
HighWomen's Multi With Fruits & Vegetables
Spring Valley
CriticalAPOKRA Breastfeeding Vegan
Apokra
CriticalDéodorant stick fleur de coton
Respire
MinorDéodorant stick Menthe Eucalyptus
Respire
MinorDéodorant stick fleur de coton
Respire
MinorProvence
Davon Du Midi
MinorVolumising Mascara - Brown
Green People
MinorThe deodorant balm. Halcyon summers
AKT
High
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Evidence
No graded sources yet for Magnesium oxide. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Regulatory status
No restrictions found. Magnesium oxide appears in these published regulatory listings.
USFDAinactive ingredient database9 entries — 3 administration routes
- Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 173 mgSource →
- Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 20 mgSource →
- Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 78 mgSource →
- Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 75 mgSource →
- Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 63 mgSource →
- Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 368 mgSource →
- Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 25.74 mgSource →
- Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 80 mgSource →
- Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 15 mgSource →
USEPAcommercial use observedEPA CPDat observed this chemical in 1856 composition records across product categories including Construction and building materials, Furniture and furnishings, Raw materials. EPA CPDat classifies this chemical for functional uses including Absorbent, pH regulating agent, Opacifer.
- EPA CPDat observed this chemical in 1856 composition records across product categories including Construction and building materials, Furniture and furnishings, Raw materials. EPA CPDat classifies this chemical for functional uses including Absorbent, pH regulating agent, Opacifer.Source →
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 80 active drug products and 83 total products.
- FDA NDC lists this ingredient in 80 active drug products and 83 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →